ACIU
AC Immune S.A.
NASDAQ · Healthcare · Biotechnology · CH
$2.86
−2.39%Leverage
- Debt / equity
- 0.12x
- Net debt / equity
- -0.67x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.10x
- Net debt / EBITDA
- 0.56x
Liquidity & coverage
- Current ratio
- 0.93x
- Quick ratio
- 0.93x
- Cash ratio
- 0.75x
- Interest coverage
- -263.40x
- EBITDA / interest
- -250.45x
- Working capital
- -$8.5M
Cash & dividend
- FCF / debt
- -8.52x
- Cash flow / debt
- -8.48x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026